Impact of biomarkers on non-small cell lung cancer treatment

ISSN： 1776-2596

Source： Targeted Oncology, Vol.5, Iss.1, 2010-03, pp. : 5-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of EGFR mutations on treatment of non-small cell lung cancer

By Johnson Bruce Jackman David Jänne Pasi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

Impact of EGFR mutations on treatment of non-small cell lung cancer

By Johnson Bruce Jackman David Jänne Pasi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F. Cueva J. Grana B. Curiel T. Leon L. Vazquez F. Candamio S. Lopez R.

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite

The role of new agents in the treatment of non-small cell lung cancer

By Broker L.E. Giaccone G.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2347-2361

Elsevier

Access to resources Recommend Favorite

Medical Management of Non-small Cell Lung Cancer

By Smith I.E.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 818-819

Elsevier

Access to resources Recommend Favorite